Dianthus Therapeutics Stock (NASDAQ: DNTH) stock price, news, charts, stock research, profile.
You can purchase shares of Dianthus Therapeutics (NASDAQ:DNTH) through any online brokerage.
Other companies in Dianthus Therapeutics’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), Replimune Group (NASDAQ:REPL) and Tango Therapeutics (NASDAQ:TNGX).
Dianthus Therapeutics has a consensus price target of $44.67.
The stock price for Dianthus Therapeutics (NASDAQ: DNTH) is $27.02 last updated September 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Dianthus Therapeutics.
Dianthus Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Dianthus Therapeutics.
Dianthus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.